,outcome,arm 1,arm 2
0,intervention,pioglitazone,glimepirede
0,"baseline, end of the study, reductions in HbA ( 1c )",-0.78 %,NR
0,"end of the study, reductions in HbA ( 1c )",NR,-0.68 %
